Review



human retinoic acid elisa kit  (Cusabio)


Bioz Verified Symbol Cusabio is a verified supplier
Bioz Manufacturer Symbol Cusabio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Cusabio human retinoic acid elisa kit
    Human Retinoic Acid Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human retinoic acid elisa kit/product/Cusabio
    Average 94 stars, based on 9 article reviews
    human retinoic acid elisa kit - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    human retinoic acid elisa kit  (Cusabio)
    94
    Cusabio human retinoic acid elisa kit
    Human Retinoic Acid Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human retinoic acid elisa kit/product/Cusabio
    Average 94 stars, based on 1 article reviews
    human retinoic acid elisa kit - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    human retinoic acid elisa kit  (Biorbyt)
    93
    Biorbyt human retinoic acid elisa kit
    (A) <t>Retinoic</t> acid concentration in the separated media and exosome fractions of CCM and Dopamine-CCM. Shown is RA concentration (pM) +/- SEM, n=3. Exosomal concentration was adjusted for full CCM volume. (B) Paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in serum containing medium (10% serum) with/without RA (1µM), RAR inhibitor AGN193109 (1µM) or both.Shown is mean contraction (%) +/- SEM, n=3. (C) CCM and dopamine-CCM were prepared from paediatric choroid cells and used to stimulate paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in the presence of RA (1µM), RAR inhibitor AGN193109 (1µM) or both. Shown is mean contraction (%) +/- SEM, n=3. (D) Paediatric choroid cells (Choro9L) were treated with 10nM dopamine with/without 8µM WIN18446 for 24hrs, after which the medium was replaced with the serum-free medium for 24 hours to generate CCM and Dopamine-CCM. These were used to stimulate scleral fibroblasts (HSF9-Posterior) contraction. Shown as mean fold change in contraction (compared to serum free medium) +/- SEM (n=4). * P<0.05, ** P<0.01, (One- or Two-way way ANOVA and Tukey’s multiple comparisons tests).
    Human Retinoic Acid Elisa Kit, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human retinoic acid elisa kit/product/Biorbyt
    Average 93 stars, based on 1 article reviews
    human retinoic acid elisa kit - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    retinoic acid elisa kit  (Cusabio)
    94
    Cusabio retinoic acid elisa kit
    (A) <t>Retinoic</t> acid concentration in the separated media and exosome fractions of CCM and Dopamine-CCM. Shown is RA concentration (pM) +/- SEM, n=3. Exosomal concentration was adjusted for full CCM volume. (B) Paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in serum containing medium (10% serum) with/without RA (1µM), RAR inhibitor AGN193109 (1µM) or both.Shown is mean contraction (%) +/- SEM, n=3. (C) CCM and dopamine-CCM were prepared from paediatric choroid cells and used to stimulate paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in the presence of RA (1µM), RAR inhibitor AGN193109 (1µM) or both. Shown is mean contraction (%) +/- SEM, n=3. (D) Paediatric choroid cells (Choro9L) were treated with 10nM dopamine with/without 8µM WIN18446 for 24hrs, after which the medium was replaced with the serum-free medium for 24 hours to generate CCM and Dopamine-CCM. These were used to stimulate scleral fibroblasts (HSF9-Posterior) contraction. Shown as mean fold change in contraction (compared to serum free medium) +/- SEM (n=4). * P<0.05, ** P<0.01, (One- or Two-way way ANOVA and Tukey’s multiple comparisons tests).
    Retinoic Acid Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retinoic acid elisa kit/product/Cusabio
    Average 94 stars, based on 1 article reviews
    retinoic acid elisa kit - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Retinoic acid concentration in the separated media and exosome fractions of CCM and Dopamine-CCM. Shown is RA concentration (pM) +/- SEM, n=3. Exosomal concentration was adjusted for full CCM volume. (B) Paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in serum containing medium (10% serum) with/without RA (1µM), RAR inhibitor AGN193109 (1µM) or both.Shown is mean contraction (%) +/- SEM, n=3. (C) CCM and dopamine-CCM were prepared from paediatric choroid cells and used to stimulate paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in the presence of RA (1µM), RAR inhibitor AGN193109 (1µM) or both. Shown is mean contraction (%) +/- SEM, n=3. (D) Paediatric choroid cells (Choro9L) were treated with 10nM dopamine with/without 8µM WIN18446 for 24hrs, after which the medium was replaced with the serum-free medium for 24 hours to generate CCM and Dopamine-CCM. These were used to stimulate scleral fibroblasts (HSF9-Posterior) contraction. Shown as mean fold change in contraction (compared to serum free medium) +/- SEM (n=4). * P<0.05, ** P<0.01, (One- or Two-way way ANOVA and Tukey’s multiple comparisons tests).

    Journal: bioRxiv

    Article Title: Dopamine selectively regulates pediatric sclera/choroid interactions through the stimulation of exosome-associated retinoic acid

    doi: 10.1101/2025.07.13.664562

    Figure Lengend Snippet: (A) Retinoic acid concentration in the separated media and exosome fractions of CCM and Dopamine-CCM. Shown is RA concentration (pM) +/- SEM, n=3. Exosomal concentration was adjusted for full CCM volume. (B) Paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in serum containing medium (10% serum) with/without RA (1µM), RAR inhibitor AGN193109 (1µM) or both.Shown is mean contraction (%) +/- SEM, n=3. (C) CCM and dopamine-CCM were prepared from paediatric choroid cells and used to stimulate paediatric scleral fibroblast (HSF9-posterior) collagen gel contraction in the presence of RA (1µM), RAR inhibitor AGN193109 (1µM) or both. Shown is mean contraction (%) +/- SEM, n=3. (D) Paediatric choroid cells (Choro9L) were treated with 10nM dopamine with/without 8µM WIN18446 for 24hrs, after which the medium was replaced with the serum-free medium for 24 hours to generate CCM and Dopamine-CCM. These were used to stimulate scleral fibroblasts (HSF9-Posterior) contraction. Shown as mean fold change in contraction (compared to serum free medium) +/- SEM (n=4). * P<0.05, ** P<0.01, (One- or Two-way way ANOVA and Tukey’s multiple comparisons tests).

    Article Snippet: Human Retinoic Acid ELISA Kit (Biorbyt, UK, Cat# orb407080) was used to measure RA concentration following the manufacturer’s protocol.

    Techniques: Concentration Assay